| Teva Pharma AG - Ondansetron-Teva 4 oro, Schmelztabletten | | 58219 | | 03 | | Ondansetron-Teva 4 oro | | Schmelztabletten | | A04AA01 | | Ondansetron | | 04.03.2010 | | |
| | Composition | | ondansetronum 4 mg, magnesii stearas, lactosum monohydricum 55.906 mg, hydroxypropylcellulosum substitutum humile, crospovidonum, calcii silicas, silica colloidalis anhydrica, aromatica (Pfefferminz) aspartamum 994 µg, pro compresso. | | Packungsbestandteile | | Melting tablets | | | | | Active Agent | Dose |
|---|
| Ondansetron | 4 mg |
| | BAG: Active Agent | Dose |
|---|
| Ondansetron | 4 mg |
| | | | Inactive agents | Dose |
|---|
| Aromatica (Pfefferminz) Aspartamum | 994 µg | | Calcii Silicas | | | Crospovidonum | | | Hydroxypropylcellulosum Substitutum Humile | | | Lactose Monohydrate | 55.906 mg | | Magnesii Stearas | | | Pro Compresso | | | Silica Colloidalis Anhydrica | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 10 Tablet(s) | 22.60 | 40.95 | B | SL | No |
|
|
